We work with international pharmaceutical and biotechnology companies to communicate the clinical and economic value of your product and service offering to your European payer customers. We support you at all phases of the product life cycle, from launch pricing projections and identifying trial outcomes through national pricing and reimbursement and Health Technology Assessment submissions to maintaining your competitive position once you have launched.